Stage IIIC Prostate Cancer AJCC v8 Recruiting Phase 3 Trials for Leuprolide (DB00007)

IndicationStatusPhase
DBCOND0109672 (Stage IIIC Prostate Cancer AJCC v8)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04513717Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialTreatment